Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik A Barth

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Prostate|December 8, 2022
A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancerJaroslav Juracek, Marie Madrzyk, Michal Stanik, et al.
Frontiers in Oncology|March 31, 2023
Optimization of postoperative surveillance protocols in upper tract urothelial cancer: A retrospective cohort studyAndrea Katharina Lindner, Martin Pichler, Sarah Maier, et al.
Cancers|August 27, 2021
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent MechanismsFlorian Posch, Felix Prinz, Amar Balihodzic, et al.
Frontiers in Immunology|April 3, 2023
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinomaRenate Pichler, Peter J Siska, Piotr Tymoszuk, et al.
Cancers|July 9, 2020
The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic CancerMichael Stotz, Dominik A Barth, Jakob M Riedl, et al.
Cancers|May 14, 2020
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell CancerMaximilian Seles, Georg C Hutterer, Johannes Foßelteder, et al.
World Journal of Urology|April 6, 2023
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgeryValentina Egger, Georg C Hutterer, Johannes Mischinger, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysisJakob M Riedl, Florian Posch, Lena Horvath, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Prostate|December 8, 2022
A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancerJaroslav Juracek, Marie Madrzyk, Michal Stanik, et al.
Frontiers in Oncology|March 31, 2023
Optimization of postoperative surveillance protocols in upper tract urothelial cancer: A retrospective cohort studyAndrea Katharina Lindner, Martin Pichler, Sarah Maier, et al.
Cancers|August 27, 2021
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent MechanismsFlorian Posch, Felix Prinz, Amar Balihodzic, et al.
Frontiers in Immunology|April 3, 2023
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinomaRenate Pichler, Peter J Siska, Piotr Tymoszuk, et al.
Cancers|July 9, 2020
The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic CancerMichael Stotz, Dominik A Barth, Jakob M Riedl, et al.
Cancers|May 14, 2020
Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell CancerMaximilian Seles, Georg C Hutterer, Johannes Foßelteder, et al.
World Journal of Urology|April 6, 2023
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgeryValentina Egger, Georg C Hutterer, Johannes Mischinger, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
Therapeutic Advances in Medical Oncology|November 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-upHannah Fluhrer, Georg C Hutterer, Sylvia Golbeck, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysisJakob M Riedl, Florian Posch, Lena Horvath, et al.
Pageof 3